Acumen Research and Consulting Blood Culture Test Market is Anticipated to Surpas | Page 3

infections, the bacterial infection segment was leading the sales market in 2018. During the forecast period the segment will also record the highest CAGR. It is anticipated, in developing countries such as South Africa, Tanzania, China, India and Argentina, that increased awareness of healthcare and health care infrastructures will foster growth for this sector. These countries’ governments are striving to deliver better quality healthcare facilities and diagnostic products that further support adoption. Due to BSI prevalence and an increasing number of cases of septicism worldwide, the fungal infections segment is projected to show profitable growth over a study period. For example, Candida species are the dominant fungal sepsis agents, representing approximately 10 to 15% of infections in health care. View Detail Information with Complete TOC@ https://www.acumenresearchandconsulting.com/blood- culture-test-market Hospital Laboratories accounted for the prime market share in terms of revenue in 2018 In 2018, the largest market share of revenue was in hospital laboratories. This is because hospital acquired infections (HAIs) are increasingly present. According to the WHO, the rate in developed developing countries is about two to three times greater than in developed countries of ICU infections acquired, Would like to place an order or any question, please feel free to contact at [email protected] | [phone]